"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, El Paso Cancer Treatment Ctr conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 29 clinical trials were completed, i.e. on average, 120.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "El Paso Cancer Treatment Ctr" #1 sponsor was "US Oncology Research" with 11 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "El Paso Cancer Treatment Ctr" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Sanofi" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "El Paso Cancer Treatment Ctr" are "Breast Cancer" (17 trials), "Metastatic Breast Cancer" (7 trials), "Prostate Cancer" (3 trials), "Advanced Breast Cancer" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "El Paso Cancer Treatment Ctr" in a lesser frequency.

Most popular intervention types in "El Paso Cancer Treatment Ctr" are "Drug" (58 trials), "Other" (7 trials), "Biological" (5 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (8 trials), "Placebo" (7 trials), "Docetaxel" (6 trials), "Cyclophosphamide" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "El Paso Cancer Treatment Ctr" are 43 trials for "All" genders, 16 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "El Paso Cancer Treatment Ctr". undefined are not yet recruiting, 7 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in El Paso Cancer Treatment Ctr, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in El Paso Cancer Treatment Ctr, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".